Clinical Trial Results:
ESTUDIO DE LA EFICACIA Y SEGURIDAD
DEL ANTIHISTAMÍNICO V0114CP 2,5 MG
EN EL TRATAMIENTO DE LA RINITIS ALÉRGICA ESTACIONAL.
ESTUDIO ALEATORIZADO, DOBLE CIEGO, DE TRES RAMAS Y GRUPOS PARALELOS, QUE INCLUYE UNA RAMA DE PLACEBO Y OTRA
DE CONTROL ACTIVO (LEVOCETIRIZINA 5 MG)
EFFICACY AND SAFETY STUDY
OF THE ANTIHISTAMINE V0114CP 2.5MG
IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS.
RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY
INCLUDING PLACEBO AND ACTIVE CONTROL ARM (LEVOCETIRIZINE 5 MG).
Summary
|
|
EudraCT number |
2008-008734-36 |
Trial protocol |
ES LT DE PL SK EE HU BE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Jan 2021
|
First version publication date |
24 Jan 2021
|
Other versions |
|
Summary report(s) |
V00114 CP 305_results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.